Results 71 to 80 of about 25,663 (196)

Effectiveness of empiric aztreonam compared to other beta-lactams for treatment of Pseudomonas aeruginosa infections

Infection and Drug Resistance, 2018
Michael Hogan,1 Mary Barna Bridgeman,1 Gee Hee Min,1 Deepali Dixit,1 Patrick J Bridgeman,1 Navaneeth Narayanan1,2 1Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, USA; 2Division of ...
Hogan M, Bridgeman MB, Min GH, Dixit D, Bridgeman PJ, Narayanan N   +5 more
doaj  

Aztreonam.

Indian pediatrics, 2006
Aztreonam belongs to the monobactam group of naturally occurring antibiotic compounds characterized by a monocycling ring structure. Aztreonam is the first monobactam that has been approved for use in pediatric medicine by US FDA in the year 1998.
Seema, Kapoor, Geeta, Gathwala
openaire   +1 more source

Evaluation of the in vitro susceptibility of clinical isolates of NDM-producing Klebsiella pneumoniae to new antibiotics included in a treatment regimen for infections

Frontiers in Microbiology
BackgroundDue to the growing resistance to routinely used antibiotics, the search for new antibiotics or their combinations with effective inhibitors against multidrug-resistant microorganisms is ongoing.
Natalia Słabisz, Patrycja Leśnik, Jarosław Janc, Miłosz Fidut, Marzenna Bartoszewicz, Ruth Dudek-Wicher, Urszula Nawrot   +6 more
doaj   +1 more source

The Role of the Gut Microbiota in Allogeneic Hematopoietic Cell Transplantation

American Journal of Hematology, Volume 101, Issue 8, Page 1980-1996, August 2026.
ABSTRACT Allogeneic hematopoietic cell transplantation (allo‐HCT) is an effective treatment for patients with high‐risk hematologic malignancies. Over the last decade, gut microbiota composition during allo‐HCT has been associated with patients' outcomes.
Wenjing Hao, Nicolas Stocker, Béatrice Gaugler, Mohamad Mohty, Florent Malard   +4 more
wiley   +1 more source

Synergistic Effect of Ceftazidime-Avibactam with Aztreonam on Carbapenemase-Positive Klebsiella pneumoniae MBL+, NDM+ [PDF]

Mateusz Szymański,1,2 Małgorzata M Skiba,2 Małgorzata Piasecka,2 Alina Olender3 1Human Anatomy Department, Medical University, Lublin, Poland; 2Intensive Care Unit, Stefan Cardinal Wyszyński District Specialist Hospital ...
Szymański M, Olender A, Skiba MM, Piasecka M   +3 more
core  

High-dose aztreonam potentiates the combined antimicrobial activity of ceftazidime-avibactam against extensively drug-resistant New Delhi metallo-β-lactamase positive Pseudomonas aeruginosa in severe pneumonia treatment: the first global case report

Frontiers in Cellular and Infection Microbiology
Extensively drug-resistant Pseudomonas aeruginosa (XDR-PA) present increasing incidence and limited therapeutic options, emerging as one of the serious public health threats worldwide.
Yifeng Liu, Yifeng Liu, Cuiju Mo, Cuiju Mo, Meng Li, Meng Li   +5 more
doaj   +1 more source

Stabilität und Kompatibilität von Aztreonam in Peritonealdialyselösungen

, 2015
Ziel der Arbeit war es, zu beurteilen, ob das Antibiotikum Aztreonam in Peritonealdialyselösungen stabil und kompatibel ist. Dazu wurde der Gehalt von Aztreonam in vier verschiedenen Peritonealdialyselösungen bei drei Lagerungstemperaturen mit Hilfe von ...
Prager, Isabella
core  

Aztreonam in surgical infections

, 1988
Aztreonam (Azactam) Uludağ Üniversitesi Tıp Fakültesi Genel Cerrahi Kliniğinde cerrahi enfeksiyonu olan 16 hastada tek antibiyotik olarak kullanıldı.

core  

In vitro antimicrobial effects of aztreonam, colistin, and the 3-drug combination of aztreonam, ceftazidime and amikacin on metallo-β-lactamase-producing Pseudomonas aeruginosa [PDF]

, 2009
Background There are limited choice of antimicrobial agents to treat infection with metallo-β-lactamase-producing Pseudomonas aeruginosa. We evaluate the antimicrobial effects of aztreonam alone, colistin alone and the 3-drug combination of aztreonam ...
Masuda Yuki, Yamamoto Masaya, Yumi Fukui, Masaya Yamamoto, Fukui Yumi, Akira Kamiya, Shigeharu Oie, Oie Shigeharu, Yuki Masuda, Kamiya Akira   +9 more
core   +2 more sources

Rapid Aztreonam/Avibactam NP test for detection of aztreonam/avibactam susceptibility/resistance in Enterobacterales

, 2023
Aztreonam-avibactam (AZA), a newly developed β-lactam/β-lactamase inhibitor combination, is a treatment option for infections due to carbapenem-resistant Enterobacterales (CRE), including metallo-ß-lactamase producers, regardless of additional production
Maxime Bouvier, Laurent Poirel, Sadek, M., Kerbol, A., Poirel, L., Nordmann, P., Mustafa Sadek, Clément Viguier, Patrice Nordmann, Viguier, C., Auriane Kerbol, Bouvier, M.   +11 more
core   +1 more source